November 05, 2024 at 10:33 am

Bionomics (BNOX) Soars After Securing AUS$1M Milestone Payment from Carina Biotech; Shares Up 185%

Bionomics Limited (NASDAQ: BNOX), a biotech company specializing in treatments for central nervous system disorders, has received a milestone payment of AUS$1 million from Carina Biotech. This payment is part of an exclusive worldwide license agreement for BNC101, a monoclonal antibody targeting the cancer stem cell antigen LGR5, which Carina is investigating for CAR-T cell… [Read More]
November 05, 2024 at 9:01 am

SNDL Takes Bite Out of Canadian Cannabis Market. Emerges as Leading Producer of Edibles Upon Closing of Indiva Acquisition

PRISM Cannabis Index company SNDL Inc. (SNDL) announced today that it has successfully completed its acquisition of Indiva Limited as part of the ongoing Companies’ Creditors Arrangement Act (“CCAA”) proceedings. The acquisition, approved through a reverse vesting order by the Ontario Superior Court of Justice was achieved through a credit bid. The estimated value of… [Read More]
November 04, 2024 at 1:35 pm

Toyota and Joby Take Flight: First International Air Taxi Demo Showcases the Future of Clean, Quiet Urban Mobility

Toyota Motor Corporation (NYSE:TM) and Joby Aviation (NYSE:JOBY) recently completed Joby’s first international air taxi demonstration flight in Japan at Toyota’s Higashi-Fuji Technical Center in Shizuoka. This flight marked an important milestone in their partnership, which spans nearly seven years. Joby’s electric air taxi, capable of carrying a pilot and four passengers at speeds of… [Read More]
November 04, 2024 at 1:17 pm

Pre-Clinical Data Shows Corbus’ CRB-913 Could Sustain and Boost Weight Loss Following Semaglutide Therapy

Corbus Pharmaceuticals (NASDAQ: CRBP) recently presented pre-clinical data on its investigational obesity treatment, CRB-913, at Obesity Week 2024. CRB-913, a CB1 inverse agonist with highly restricted peripheral action, demonstrated a significant impact on weight loss in diet-induced obesity (DIO) mice.   Key findings included: Brain Levels and Safety Profile: CRB-913 exhibited brain levels 15 times… [Read More]
November 04, 2024 at 10:06 am

Could a New Era in Alzheimer’s Research Bring an End to Dementia as We Know It?

New Therapeutic Approaches and Targets Offer Hope for Alzheimer’s Patients The Alzheimer’s disease treatment landscape is rapidly evolving, fueled by increased research and innovative therapies that bring new hope to patients and families. Alzheimer’s, the most common form of dementia, impacts nearly 7 million Americans—a number projected to double by 2060. While the disease remains… [Read More]
November 04, 2024 at 9:31 am

PRISM Spotlight: Sidus Space Is on a Mission That Is Out of This World

Sidus Space (SIDU) is a space mission enabler that provides flexible, cost-effective solutions including custom satellite design, payload hosting, mission management, space manufacturing and AI enhanced space-based sensor data-as-a-service for government, defense, intelligence, and commercial companies around the globe has been added to the PRISM NextGen Tech and AI Index. Founded in 2012, with its… [Read More]